New Studies

New studies reveal significant medical progression for mesothelioma patients of all stages. Know which treatments are working best and which aren’t.

Asbestos | Diagnosis | Glocal | International | New Studies | Research | Scans

Miner Study Finds Mesothelioma Often Undiagnosed
ByAlex Strauss August 31, 2017August 31, 2017

A new study of former South African mine workers suggests that too many asbestos-related diseases may be going undiagnosed. The…

Read More Miner Study Finds Mesothelioma Often Undiagnosed
New Studies | Prognosis | Research | Surgery | Treatments

New Research Finds Little Survival Difference Between Mesothelioma Surgeries
ByAlex Strauss August 29, 2017

The largest analysis of mesothelioma surgery ever done finds little survival difference between lung-sparing and lung-removing surgeries. A team of…

Read More New Research Finds Little Survival Difference Between Mesothelioma Surgeries
Alternatives | Europe | Holistic | International | New Studies | Research | Treatments

Preventing and Treating Mesothelioma with Phytochemicals
ByAlex Strauss August 27, 2017

Italian scientists say it may one day be possible to treat or even prevent malignant mesothelioma by harnessing the powerful…

Read More Preventing and Treating Mesothelioma with Phytochemicals
Chemotherapy | Multi-Modality Therapy | New Studies | Prognosis | Research | Statistics | Treatments

New Report Reveals Disparities in Mesothelioma Treatment
ByAlex Strauss August 23, 2017

A new study of mesothelioma treatment and survival in the US contains some disturbing facts about treatment trends. Among them…

Read More New Report Reveals Disparities in Mesothelioma Treatment
Multi-Modality Therapy | New Studies | Research | Statistics | Surgery | Treatments

10-Year Study Confirms Longer Mesothelioma Survival with Trimodal Therapy
ByAlex Strauss August 19, 2017September 11, 2017

Trimodality therapy including surgery, chemotherapy, and radiation appears to give carefully-selected patients the best odds of surviving mesothelioma. In a…

Read More 10-Year Study Confirms Longer Mesothelioma Survival with Trimodal Therapy
Chemotherapy | Europe | International | New Studies | Research | Treatments

Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival
ByAlex Strauss August 12, 2017

German surgeons are reporting on a potential new way to improve outcomes for people with malignant pleural mesothelioma by infusing…

Read More Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival
Europe | International | Multi-Modality Therapy | New Drugs | New Studies | Research | Treatments

Long-Term Peritoneal Mesothelioma Survival with Apitolisib
ByAlex Strauss August 2, 2017

There is hopeful news this week about the survivability of peritoneal mesothelioma, particularly when relapses are treated with a powerful…

Read More Long-Term Peritoneal Mesothelioma Survival with Apitolisib
New Studies | Prevention | Radiation Therapy | Research | Statistics | Treatments

Radiotherapy for Lymphoma as a Risk Factor for Malignant Mesothelioma
ByAlex Strauss July 30, 2017

People who received radiotherapy for the treatment of lymphoma have a higher chance of developing malignant mesothelioma later in life.…

Read More Radiotherapy for Lymphoma as a Risk Factor for Malignant Mesothelioma
Chemotherapy | Mesothelioma Breaking News | New Drugs | New Studies | Research | Treatments

Antibody-Drug Conjugate Fails to Stop Recurrent Pleural Mesothelioma
ByAlex Strauss July 26, 2017July 26, 2017

A new drug designed to treat recurrent malignant mesothelioma while minimizing side effects has failed to meet expectations. Anetumab ravtansine,…

Read More Antibody-Drug Conjugate Fails to Stop Recurrent Pleural Mesothelioma
Immune Systems | Immunotherapy | International | New Drugs | New Studies | Research | Treatments

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival
ByAlex Strauss July 23, 2017

A large international clinical trial of the immunotherapy drug tremelimumab as a second- or third-line treatment option for malignant mesothelioma…

Read More Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

1 (888) 378-1331

New Studies

Miner Study Finds Mesothelioma Often Undiagnosed

New Research Finds Little Survival Difference Between Mesothelioma Surgeries

Preventing and Treating Mesothelioma with Phytochemicals

New Report Reveals Disparities in Mesothelioma Treatment

10-Year Study Confirms Longer Mesothelioma Survival with Trimodal Therapy

Novel Chemotherapy Technique Appears to Boost Mesothelioma Survival

Long-Term Peritoneal Mesothelioma Survival with Apitolisib

Radiotherapy for Lymphoma as a Risk Factor for Malignant Mesothelioma

Antibody-Drug Conjugate Fails to Stop Recurrent Pleural Mesothelioma

Second-Line Immunotherapy Treatment Fails to Improve Mesothelioma Survival

United States Sources

Centers for Disease Control and Prevention (CDC), UNITED STATES

Creighton University School of Medicine, UNITED STATES

David Geffen School of Medicine, UCLA, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, UNITED STATES

Mayo Clinic, UNITED STATES

Moffitt Cancer Center, Tampa, FL, UNITED STATES

National Institute for Occupational Safety & Health, UNITED STATES

University of Chicago, Medical Center, UNITED STATES

University of Maryland School of Medicine, UNITED STATES

University of Hawaii Cancer Center, UNITED STATES

Wake Forest University School of Medicine, UNITED STATES